Literature DB >> 22390766

Chemoradiotherapy of human tumors: novel approaches from nanomedicine.

Michael Edward Werner1, Michael Bonner Foote, Andrew Zhuang Wang.   

Abstract

Chemoradiotherapy is an important treatment paradigm in oncology and is part of the curative treatment for many solid cancers, such as lung, pancreatic and cervical cancers. One of the main goals in oncology research is to develop approaches that can improve the efficacy of chemoradiotherapy while minimizing treatment toxicity. A new and exciting approach is to incorporate advances in nanomedicine into chemoradiotherapy. Nanoparticles possess unique properties, such as preferential accumulation in tumors and minimal uptake in normal tissues, that make them ideally suited for delivering chemotherapy in chemoradiotherapy. In this review, we plan to discuss the rationale and evidence for applying nanomedicine to chemoradiotherapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390766     DOI: 10.2174/138161212800626229

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  Injectable (-)-gossypol-loaded Pluronic P85 micelles for cancer chemoradiotherapy.

Authors:  Keishiro Tomoda; Hsin C Chiang; Kevin R Kozak; Glen S Kwon
Journal:  Int J Radiat Biol       Date:  2016-12-09       Impact factor: 2.694

2.  Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy.

Authors:  Joseph Della Rocca; Michael E Werner; Stephanie A Kramer; Rachel C Huxford-Phillips; Rohit Sukumar; Natalie D Cummings; Juan L Vivero-Escoto; Andrew Z Wang; Wenbin Lin
Journal:  Nanomedicine       Date:  2014-07-17       Impact factor: 5.307

3.  Examination of Gossypol-Pluronic Micelles as Potential Radiosensitizers.

Authors:  Keishiro Tomoda; Carol Chiang; Kevin R Kozak; Glen S Kwon
Journal:  AAPS J       Date:  2015-08-06       Impact factor: 4.009

4.  pH- and Ultrasound-Responsive Paclitaxel-Loaded Carboxymethyl Chitosan Nanodroplets for Combined Imaging and Synergistic Chemoradiotherapy.

Authors:  Mengmeng Shang; Xiao Sun; Lu Guo; Dandan Shi; Ping Liang; Dong Meng; Xiaoying Zhou; Xinxin Liu; Yading Zhao; Jie Li
Journal:  Int J Nanomedicine       Date:  2020-01-24

5.  Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.

Authors:  Armando Lucero-Acuña; Justin J Jeffery; Edward R Abril; Raymond B Nagle; Roberto Guzman; Mark D Pagel; Emmanuelle J Meuillet
Journal:  Int J Nanomedicine       Date:  2014-12-03

Review 6.  Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications.

Authors:  Francis Boateng; Wilfred Ngwa
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.